First Time Loading...

Silk Road Medical Inc
NASDAQ:SILK

Watchlist Manager
Silk Road Medical Inc Logo
Silk Road Medical Inc
NASDAQ:SILK
Watchlist
Price: 17.46 USD -1.41% Market Closed
Updated: Apr 18, 2024

Intrinsic Value

SILK's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Silk Road Medical, Inc. develops and manufactures medical devices to treat neurovascular diseases. [ Read More ]

The intrinsic value of one SILK stock under the Base Case scenario is 20.63 USD. Compared to the current market price of 17.46 USD, Silk Road Medical Inc is Undervalued by 15%.

Key Points:
SILK Intrinsic Value
Base Case
20.63 USD
Undervaluation 15%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Silk Road Medical Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling SILK stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Silk Road Medical Inc

Provide an overview of the primary business activities
of Silk Road Medical Inc.

What unique competitive advantages
does Silk Road Medical Inc hold over its rivals?

What risks and challenges
does Silk Road Medical Inc face in the near future?

Has there been any significant insider trading activity
in Silk Road Medical Inc recently?

Summarize the latest earnings call
of Silk Road Medical Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Silk Road Medical Inc.

Provide P/S
for Silk Road Medical Inc.

Provide P/E
for Silk Road Medical Inc.

Provide P/OCF
for Silk Road Medical Inc.

Provide P/FCFE
for Silk Road Medical Inc.

Provide P/B
for Silk Road Medical Inc.

Provide EV/S
for Silk Road Medical Inc.

Provide EV/GP
for Silk Road Medical Inc.

Provide EV/EBITDA
for Silk Road Medical Inc.

Provide EV/EBIT
for Silk Road Medical Inc.

Provide EV/OCF
for Silk Road Medical Inc.

Provide EV/FCFF
for Silk Road Medical Inc.

Provide EV/IC
for Silk Road Medical Inc.

Show me price targets
for Silk Road Medical Inc made by professional analysts.

What are the Revenue projections
for Silk Road Medical Inc?

How accurate were the past Revenue estimates
for Silk Road Medical Inc?

What are the Net Income projections
for Silk Road Medical Inc?

How accurate were the past Net Income estimates
for Silk Road Medical Inc?

What are the EPS projections
for Silk Road Medical Inc?

How accurate were the past EPS estimates
for Silk Road Medical Inc?

What are the EBIT projections
for Silk Road Medical Inc?

How accurate were the past EBIT estimates
for Silk Road Medical Inc?

Compare the revenue forecasts
for Silk Road Medical Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Silk Road Medical Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Silk Road Medical Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Silk Road Medical Inc compared to its peers.

Compare the P/E ratios
of Silk Road Medical Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Silk Road Medical Inc with its peers.

Analyze the financial leverage
of Silk Road Medical Inc compared to its main competitors.

Show all profitability ratios
for Silk Road Medical Inc.

Provide ROE
for Silk Road Medical Inc.

Provide ROA
for Silk Road Medical Inc.

Provide ROIC
for Silk Road Medical Inc.

Provide ROCE
for Silk Road Medical Inc.

Provide Gross Margin
for Silk Road Medical Inc.

Provide Operating Margin
for Silk Road Medical Inc.

Provide Net Margin
for Silk Road Medical Inc.

Provide FCF Margin
for Silk Road Medical Inc.

Show all solvency ratios
for Silk Road Medical Inc.

Provide D/E Ratio
for Silk Road Medical Inc.

Provide D/A Ratio
for Silk Road Medical Inc.

Provide Interest Coverage Ratio
for Silk Road Medical Inc.

Provide Altman Z-Score Ratio
for Silk Road Medical Inc.

Provide Quick Ratio
for Silk Road Medical Inc.

Provide Current Ratio
for Silk Road Medical Inc.

Provide Cash Ratio
for Silk Road Medical Inc.

What is the historical Revenue growth
over the last 5 years for Silk Road Medical Inc?

What is the historical Net Income growth
over the last 5 years for Silk Road Medical Inc?

What is the current Free Cash Flow
of Silk Road Medical Inc?

Financials

Balance Sheet Decomposition
Silk Road Medical Inc

Current Assets 240.8m
Cash & Short-Term Investments 181.5m
Receivables 23.6m
Other Current Assets 35.8m
Non-Current Assets 24.5m
Long-Term Investments 9.5m
PP&E 14.6m
Other Non-Current Assets 415k
Current Liabilities 30.3m
Accounts Payable 5.7m
Accrued Liabilities 24.5m
Other Current Liabilities 143k
Non-Current Liabilities 83.9m
Long-Term Debt 75.6m
Other Non-Current Liabilities 8.2m
Efficiency

Earnings Waterfall
Silk Road Medical Inc

Revenue
177.1m USD
Cost of Revenue
-50m USD
Gross Profit
127.1m USD
Operating Expenses
-186.4m USD
Operating Income
-59.3m USD
Other Expenses
3.5m USD
Net Income
-55.7m USD

Free Cash Flow Analysis
Silk Road Medical Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

SILK Profitability Score
Profitability Due Diligence

Silk Road Medical Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

32/100
Profitability
Score

Silk Road Medical Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

SILK Solvency Score
Solvency Due Diligence

Silk Road Medical Inc's solvency score is 48/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Low D/E
Long-Term Solvency
48/100
Solvency
Score

Silk Road Medical Inc's solvency score is 48/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SILK Price Targets Summary
Silk Road Medical Inc

Wall Street analysts forecast SILK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SILK is 20.57 USD with a low forecast of 8.08 USD and a high forecast of 29.4 USD.

Lowest
Price Target
8.08 USD
54% Downside
Average
Price Target
20.57 USD
18% Upside
Highest
Price Target
29.4 USD
68% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

SILK Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

SILK Price
Silk Road Medical Inc

1M 1M
+3%
6M 6M
+139%
1Y 1Y
-60%
3Y 3Y
-66%
5Y 5Y
-49%
10Y 10Y
-52%
Annual Price Range
17.46
52w Low
6.29
52w High
46.14
Price Metrics
Average Annual Return 13.32%
Standard Deviation of Annual Returns 29.69%
Max Drawdown -91%
Shares Statistics
Market Capitalization 683.8m USD
Shares Outstanding 39 174 600
Percentage of Shares Shorted 10.63%

SILK Return Decomposition
Main factors of price return

What is price return decomposition?

SILK News

Last Important Events
Silk Road Medical Inc

Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.

All
Positive
Negative

Sentiment Analysis
Silk Road Medical Inc

Today
Last 7 Days 7D
Last 30 Days 30D
Last 90 Days 90D

Company Profile

Silk Road Medical Inc Logo
Silk Road Medical Inc

Country

United States of America

Industry

Health Care

Market Cap

683.8m USD

Dividend Yield

0%

Description

Silk Road Medical, Inc. develops and manufactures medical devices to treat neurovascular diseases. The company is headquartered in Sunnyvale, California and currently employs 352 full-time employees. The company went IPO on 2019-04-04. The firm has discovered an approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR), which relies on two concepts: minimally invasive direct carotid access in the neck and high-rate blood flow reversal during the procedure to protect the brain and combines the benefits of innovative endovascular techniques with fundamental surgical principles. The firm's ENROUTE Transcarotid Neuroprotection System (NPS) and ENROUTE Transcarotid Stent System are the products for use in TCAR. Its ENROUTE Transcarotid Stent System is placed during a period of temporary high-rate blood flow reversal, which is enabled by its ENROUTE Transcarotid NPS. The company markets and sells its products in the United States through a direct sales organization consisting of approximately 64 sales representatives and 62 clinical support specialists.

Contact

CALIFORNIA
Sunnyvale
1213 Innsbruck Dr
+16505669060.0
https://silkroadmed.com/

IPO

2019-04-04

Employees

352

Officers

CFO & COO
Mr. Lucas W. Buchanan
EVP, Chief Legal Officer & Secretary
Mr. Kevin M. Klemz
Chief Commercial Officer
Mr. Andrew S. Davis
Executive Vice President of Clinical, Regulatory Affairs & Quality Assurance
Mr. Richard M. Ruedy
Chief Executive Officer
Mr. Charles S. McKhann
Chief Accounting Officer & VP of Finance
Ms. Mhairi L. Jones
Show More
Compliance Officer & VP of Medical Affairs
Ms. Tammy Leitsinger
Vice President of Marketing, Business Development & Strategy
Mr. Jorge O'Hara
Vice President of Human Resources
Ms. Alison Highlander
Executive Medical Director
Dr. Sumaira MacDonald M.D., Ph.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one SILK stock?

The intrinsic value of one SILK stock under the Base Case scenario is 20.63 USD.

Is SILK stock undervalued or overvalued?

Compared to the current market price of 17.46 USD, Silk Road Medical Inc is Undervalued by 15%.